Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04949451 · ClinicalTrials.gov registry record · NA
Time Restricted Feeding, Muscle, and Metabolism
A NA study of Obesity and Overweight, sponsored by University of Arkansas, Fayetteville.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT04949451: Recruiting NA study of Obesity and Overweight, sponsored by University of Arkansas, Fayetteville.
NCT04949451 is a NA study of Obesity and Overweight that is actively recruiting participants, run by University of Arkansas, Fayetteville. The registered enrollment target is 90 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04949451, a NA study of Obesity and Overweight, is actively recruiting participants, sponsored by University of Arkansas, Fayetteville.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
Effective nutrition strategies for combatting and/or preventing obesity still need to be identified. This has been the case despite the numerous and different approaches that have been taken. Potential targets for combatting/preventing obesity have been identified, but long-term solutions have not emerged. This study uses time restricted feeding to study the role of dietary protein in obesity prevention and/or treatment. The objectives are to determine the role of skeletal muscle mass as a driver of energy-sensing mechanisms and peripheral signals that regulate appetite and energy intake in overweight and obese adults and to determine the effects of protein timing on muscle mass to regulate appetite and energy intake in overweight and obese adults.
Primary Outcome
Body composition measured using dual x-ray absorptiometry to determine the ration of lean/fat-free mass to fat mass.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Whey protein supplement
- DIETARY_SUPPLEMENT Ketogenic aid
- OTHER Control group - time restricted feeding only
Study Locations (1)
Arkansas
- University of Arkansas - Fayetteville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2021-06-13 |
| Est. Completion | 2025-12-30 |
| Phase | NA |
What NCT04949451 shows while recruiting
NCT04949451 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Whey protein supplement is the first listed.
NCT04949451 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT04949451 about?
NCT04949451 is a clinical study titled "Time Restricted Feeding, Muscle, and Metabolism". Effective nutrition strategies for combatting and/or preventing obesity still need to be identified. This has been the case despite the numerous and different approaches that have been taken. Potential targets for combatting/preventing obesity have been identified, but long-term solutions have not e...
What is the current status of trial NCT04949451?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2021-06-13. Estimated completion is 2025-12-30.
What conditions does trial NCT04949451 study?
This clinical trial studies the following conditions: Obesity, Overweight.
What interventions are being tested in trial NCT04949451?
The interventions under investigation include: Whey protein supplement (DIETARY_SUPPLEMENT), Ketogenic aid (DIETARY_SUPPLEMENT), Control group - time restricted feeding only (OTHER).
Who is sponsoring clinical trial NCT04949451?
This trial is sponsored by University of Arkansas, Fayetteville, which has 25 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04949451 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04949451's enrollment target sits among peer trials
90 520th of 1053 higher than 526 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI